# Sources — Jack London

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

Accessed November 5, 2026. The canonical source metadata and claim links are in `case.json`.

## Historical evidence

1. Jack London State Historic Park (Jack London Park Partners). “Jack London: A Brief Biography.” Born January 12, 1876; *Call of the Wild* (1903) and *The Sea Wolf* (1904); more than 50 books between 1900 and 1916; the ranch at Glen Ellen from 1905; Wolf House burned on August 22, 1913, “a crushing financial blow”; “The loss of Wolf House left London depressed, but he forced himself to go back to work”; “He continued to push to complete 1000 words per day regardless of his location, duties, or health”; “When London's doctors urged him to change his work habits and his diet, stop all use of alcohol and get more exercise, he refused”; “On November 22, 1916, 40-year-old Jack London died of gastrointestinal uremic poisoning.” https://jacklondonpark.com/jack-london-biography/
2. Stumpf A, Leal L, Hayes G, Houghton L. *Interpreting the History of Jack London* (docent presentation, 2008, revised 2018), Jack London State Historic Park. Full text read. His mother, stepfather and the astrologer William Chaney; oyster pirate at 15, fish patrol at 16, seaman at 17, tramping and a month in jail at 18, the Klondike at 21; marriage on April 7, 1900, daughters in 1901 and 1902, divorce final November 17, 1905, and remarriage two days later; the *Snark* (1907 to 1909) and “yaws”; “1913 – July: appendectomy, serious kidney damage found”; 1914, Vera Cruz and “Ill from dysentery and rheumatism”; 1915, “Jack in declining health”; death “of severe uremia.” https://jacklondonpark.com/wp-content/uploads/2023/12/Interpreting-JL-part-1-rev-2018.pdf
3. Leal L. *The Life of Jack London* (docent training text, 2017), Jack London State Historic Park. Full text read. “She had her baby with the name John Griffith Chaney on the birth certificate”; in the Klondike “Jack came home with very little after suffering scurvy”; travel log: Hawaii February 24 to July 22, 1915, and again from December 16, 1915. https://jacklondonpark.com/wp-content/uploads/2019/11/1.-LIFE-OF-JL-presentation-text-and-supplemental-information.pdf
4. Leal L. *The Death of Jack London: Fact and Fiction* (2016), Jack London State Historic Park. Full text read. The death certificate, signed by his physician, “stated the cause of death was: uraemia following renal colic”; his physician “had diagnosed a significant kidney problem back in July of 1913”; the physicians' bulletin: “a gastro-intestinal type of uraemia. He rapidly entered coma and died at 7:45 p.m., November 22, 1916”; the origin of the suicide rumor, the 1938 biographical novel's morphine vials, the physicians' denial, and a pharmacist's and physicians' analyses; a summary of Bomback and Klemmer (mercury from treatment of yaws; dermatitis of the hands, feet, cheeks and nose; morphine tolerance) and of P. K. Labor (possible lupus, after Denko; gout; tobacco, alcohol and hypertension). Correspondence cited is in the Jack London Collection, Huntington Library. https://jacklondonpark.com/wp-content/uploads/2019/12/Death-of-Jack-London-Fact-and-Fiction-by-Lou-Leal-2016.pdf
5. London J. *The Cruise of the Snark* (Project Gutenberg eBook #2512). “I don't know whether they are yaws or not—a physician in Fiji told me they were, and a missionary in the Solomons told me they were not”; “my hands have been swelling as with dropsy … the skin is peeling off both hands”; “I went to Australia to go into hospital, where I spent five weeks”; “The mysterious malady that afflicted my hands was too much for the Australian specialists”; tropical light blamed; a malady “variously called the healthy man's disease, European Leprosy, and Biblical Leprosy … my silvery skin vanished.” https://www.gutenberg.org/ebooks/2512
6. London J. *John Barleycorn* (1913) (Project Gutenberg eBook #318). “I was five years old the first time I got drunk”; “I was no hereditary alcoholic”; at the ranch “at nine sharp, invariably, I began my writing. By eleven … my thousand words were finished”; “I was beginning to drink alone. And I was beginning to drink, not for hospitality's sake, not for the sake of the taste, but for the effect of the drink.” https://www.gutenberg.org/ebooks/318
7. Bomback AS, Klemmer PJ. “Jack London's ‘chronic interstitial nephritis’: a historical differential diagnosis.” *Pharos* 2008;71(1):26-30 (PMID 18246783). PubMed record read; the argument is known from source 4. https://pubmed.ncbi.nlm.nih.gov/18246783/
8. Bomback AS, Klemmer PJ. “Jack London's ‘mysterious malady’.” *Am J Med* 2007;120(5):466-467 (PMID 17466662). PubMed record read (no abstract). https://pubmed.ncbi.nlm.nih.gov/17466662/
9. Denko CW. “Jack London. A modern analysis of his mysterious disease.” *J Rheumatol* 1993;20(10):1760-1763 (PMID 8295191). PubMed record read (no abstract). https://pubmed.ncbi.nlm.nih.gov/8295191/
10. Aronica JC, Norton SA. “The Snark and the Skin: Jack London's Pacific Voyage.” *JAMA Dermatol* 2015;151(9):1016 (PMID 26352126). PubMed record read (no abstract). https://pubmed.ncbi.nlm.nih.gov/26352126/
11. California State Parks. “Jack London State Historic Park.” Glen Ellen and the Sonoma Valley his home; Wolf House “destroyed by fire in 1913”; his grave. https://www.parks.ca.gov/?page_id=478
12. HISTMED Master Roster v3. Internal project source; not treated as independent corroboration.

## Clinical guidance

1. Kidney Disease: Improving Global Outcomes. KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. *Kidney Int* 2024;105(4S):S117-S314 (PMID 38490803): staging by eGFR and albuminuria, the heat map, the kidney failure risk equation, maximum-dose renin-angiotensin blockade in albuminuria, SGLT2 inhibitors for eGFR 20 or more with albumin 200 mg/g or more, NSAID avoidance and medicine review. https://pubmed.ncbi.nlm.nih.gov/38490803/
2. KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease (PMID 33637192): standardized office measurement and a systolic target below 120 when tolerated. https://pubmed.ncbi.nlm.nih.gov/33637192/
3. 2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults. *Circulation* 2025;152(11):e114-e218 (PMID 40811497). https://pubmed.ncbi.nlm.nih.gov/40811497/
4. CMID: Clinical Monitoring Intelligence Database (Aether Forge, 2026), chronic kidney disease, hypertension and depression monographs: potassium and creatinine two to four weeks after starting or changing a renin-angiotensin blocker or SGLT2 inhibitor; eGFR and urine albumin twice a year at G3b A2; calcium, phosphate and PTH every six to twelve months; 25-hydroxyvitamin D at baseline; urinalysis and a lipid panel once at diagnosis; yearly hemoglobin and kidney failure risk; NSAID avoidance and lifestyle at every visit; yearly vaccination review. https://patrickrutledge.github.io/topthirty/
5. Reus VI, et al. The American Psychiatric Association Practice Guideline for the Pharmacological Treatment of Patients With Alcohol Use Disorder. *Am J Psychiatry* 2018;175(1):86-90 (PMID 29301420): naltrexone or acamprosate for moderate to severe alcohol use disorder. https://pubmed.ncbi.nlm.nih.gov/29301420/
6. VA/DoD Clinical Practice Guideline for the Management of Substance Use Disorders (2021). https://www.healthquality.va.gov/guidelines/MH/sud/
7. The ASAM Clinical Practice Guideline on Alcohol Withdrawal Management (2020; PMID 32511109): PAWSS, CIWA-Ar, outpatient management for low-risk patients, thiamine. https://pubmed.ncbi.nlm.nih.gov/32511109/
8. American Association for the Study of Liver Diseases: Diagnosis and Treatment of Alcohol-Associated Liver Diseases (2019; PMID 31314133) and the Practice Guideline on blood-based noninvasive liver disease assessment (2025; PMID 38489523). https://pubmed.ncbi.nlm.nih.gov/31314133/; https://pubmed.ncbi.nlm.nih.gov/38489523/
9. VA/DoD Clinical Practice Guideline for Assessment and Management of Patients at Risk for Suicide (2024). https://healthquality.va.gov/HEALTHQUALITY/guidelines/mh/srb/index.asp
10. U.S. Preventive Services Task Force: tobacco smoking cessation (2021), depression (2023), statins (2022), HIV (2019), hepatitis C (2020), and the A and B recommendations. https://www.uspreventiveservicestaskforce.org/uspstf/recommendation-topics/uspstf-a-and-b-recommendations
11. Centers for Disease Control and Prevention: hepatitis B screening (2023; PMID 36893044), universal adult hepatitis B vaccination (ACIP 2022; PMID 35358162), hepatitis A prevention (ACIP 2020; PMID 32614811), and the Adult Immunization Schedule by Medical Condition. https://www.cdc.gov/vaccines/hcp/imz-schedules/adult-medical-condition.html
12. Medicare Preventive Services reference (Aether Forge, 2026). https://patrickrutledge.github.io/preventative_services/

## Editorial resolutions

- **Sources.** The case relies on Jack London State Historic Park (its biography and three documents by the park historian and docents, one of which cites the death certificate, the physicians' bulletin and Huntington Library correspondence), California State Parks, his own published accounts in *The Cruise of the Snark* and *John Barleycorn* (Project Gutenberg), and the PubMed records of Bomback and Klemmer (2007, 2008), Denko (1993) and Aronica and Norton (2015), none of which has an abstract; their arguments are taken only as summarized by the park historian. The Huntington Library (rate-limited), Sonoma State University's Jack London collection and the Library of Congress pages (access refused) could not be read.
- **Name.** The display name is “Jack London”; his birth name, “John Griffith Chaney,” is the alias and appears in no other record. Neither “Jack” nor “London” alone is an alias, because both words appear in other records. “Griffith” appears only inside the full birth name; the display names of the two other records that contain that word are never written. No other figure with a record is named; a writer whom the park biography quotes in comparison with him is left out.
- **Index age and dates.** The index visit on August 4, 2026 maps to August 4, 1915, at Glen Ellen, when he was 39: two years after kidney damage was found at his appendectomy in July 1913, and two weeks after he came home from Hawaii on July 22, 1915. The synthetic date of birth is January 12, 1987 (shift 111 years). The visits on August 18, September 1, 15 and 29, and October 13 and 27, 2026 map to the same days of 1915, before he sailed for Hawaii again on December 16, 1915. The sources do not say where he was each day of that autumn; the ranch is assumed. Past medical history includes only events up to 1914; claims about 1916 and after are kept out of the intake documents.
- **Kidney disease (CLM-0009, CLM-0013, D).** Kidney damage found in July 1913 and death from “uraemia following renal colic” are documented; the nature and cause of his kidney disease are not. The modern episode gives a synthetic cause, hypertension with two years of daily naproxen, chosen as common, teachable and consistent with the documented rheumatism (the joint pain that leads to naproxen). The ultrasound shows no stones, so the record does not claim that he had stones in 1915; the renal colic of his last illness is recorded only as history.
- **Retrospective diagnoses (CLM-0007, R, disputed).** The “silvery skin” read as psoriasis, the hand malady, mercury from the treatment of yaws as a cause of his kidney disease, lupus, gout, and the effects of tobacco and alcohol are recorded once as disputed interpretations and are not used as diagnoses. His own account of the *Snark* illnesses (CLM-0006) is graded D as his account; the yaws diagnosis was itself disputed by those who saw him, so the past medical history entry is graded R.
- **Morphine and suicide (CLM-0014, R, disputed; sensitive).** The record takes neither side. The story that he took his own life, the morphine vials of a 1938 biographical novel, his physicians' denial, and the argument that kidney failure would let a usual dose of morphine accumulate are recorded once, as later history, linked to the 1916 timeline event so that the intake documents do not show them. The modern episode does not use them: its opioid caution rests on naltrexone, kidney disease and early recovery.
- **Alcohol (CLM-0008, D; sensitive).** His drinking is recorded in his own published words. The modern severe alcohol use disorder, its seven DSM-5-TR criteria, the amounts, the AUDIT of 27 and the PEth values are synthetic and are not a claim about his real drinking. The claim that his doctors urged him to stop drinking and he refused (CLM-0012) is undated in the source and is linked to the 1916 event so that it is not shown at intake.
- **Mood (CLM-0015, R, disputed; sensitive).** The roster's depression and probable bipolar disorder are not documented as diagnoses in the sources read and are not used. The park's statement that the loss of Wolf House left him “depressed” is kept as its words (CLM-0005). The modern PHQ-9 is 9 at intake with item 9 scored 0 and falls to 4.
- **Safety assessment.** Required by the alcohol use disorder code. It records no current suicidal ideation, intent or plan, lethal-means counseling for the rifle and shotgun on the ranch (locked in the ranch office safe with the ammunition apart), five days' supply of chlordiazepoxide with daily telephone checks, a written safety plan and the 988 Suicide & Crisis Lifeline. Safety is reviewed at every later visit. The firearms are synthetic.
- **Relatives.** His mother, stepfather, the astrologer named on his birth certificate, his two wives and two daughters appear only as documented history (CLM-0001, CLM-0016) and as “married; two daughters from an earlier marriage.” Their statements about his death in source 4 are not used. The advance care planning agent is unnamed. No relative has any statement, decision or health fact in the modern episode. No family medical history is recorded.
- **Clinical judgment calls.** (1) Losartan started at intake for hypertension with albuminuria, before the consultation, with potassium and creatinine at two weeks; raised to 100 mg at six weeks. (2) Outpatient withdrawal with a five-day fixed chlordiazepoxide taper (low withdrawal-risk score, no cirrhosis, no past seizures or delirium), dispensed for five days only with daily telephone checks, and thiamine. (3) Naltrexone chosen over acamprosate: no kidney dose change, liver tests acceptable, no opioid use, and a once-daily schedule; acamprosate needs 333 mg three times a day at a creatinine clearance of 30 to 50 mL/min and is avoided at 30 or below. (4) Dapagliflozin delayed until ten weeks (six weeks after his one lapse), because heavy drinking, missed meals and vomiting raise the risk of ketoacidosis; he met the KDIGO recommendation (eGFR 20 or more and albumin 200 mg/g or more). (5) No kidney biopsy: bland sediment, moderate albuminuria and a clear hypertensive and NSAID history. (6) Uric acid of 8.4 mg/dL not treated without gout. (7) No statin at 39 without diabetes, heart disease or stroke (KDIGO). (8) Acetaminophen limited to 2,000 mg a day after heavy drinking; a short course of topical diclofenac for the sprain accepted because blood levels are low. (9) Liver stiffness of 7.2 kPa read as advanced fibrosis unlikely, with the caveat that stiffness reads high soon after heavy drinking. (10) Vaccines for kidney and liver disease, alcohol use disorder and smoking: influenza, PCV20, hepatitis B (two doses) and hepatitis A. (11) Smoking addressed but cessation deferred at his request until he is surer of his sobriety.
- **Synthetic clinical picture.** Everything in the modern episode is synthetic: every result, the urinalysis, ultrasound and elastography, the insurance creatinine, the hepatitis and HIV results (recorded as narrative), the CIWA-Ar, PAWSS and FIB-4 values, the kidney failure risk, the examination findings, the scores (AUDIT, PHQ-9, PHQ-2, GAD-7), the medicines and the outcomes. Height (173 cm) and weights are synthetic.
- **Preventive visit.** A periodic adult preventive visit at 39 (CPT 99395 with 99497 in plain text). Judgment calls: influenza, PCV20, hepatitis B and hepatitis A vaccines; COVID-19 vaccine at the pharmacy; HIV, hepatitis B and hepatitis C screening done at the consultation; colorectal and lung cancer screening not yet indicated; a dental visit for gum disease; advance care planning that will be revisited before any discussion of dialysis.
- **Sick visit.** A right ankle sprain from stepping into a burrow on the ranch, chosen because it tests the plan: no oral NSAIDs with kidney disease, no opioid on naltrexone, acetaminophen within a lower limit and a short course of topical diclofenac, the Ottawa ankle rules, and one evening of drinking for the pain, handled as a lapse with a safety review. It is not a historical claim.
- **Focused visits.** The four chronic-care follow-ups (two weeks with the consultation, six, ten and twelve weeks) are documented as focused visits on the CMID chronic kidney disease and hypertension monographs with KDIGO 2024, KDIGO 2021 and the 2025 AHA/ACC guideline, the APA 2018 and VA/DoD 2021 alcohol use disorder guidelines, the ASAM withdrawal guideline, the AASLD liver guidance and the VA/DoD suicide-risk guideline. One deviation is recorded instead of an invented result: the baseline 25-hydroxyvitamin D was left off the intake order; no harm was likely with normal calcium and phosphate and a mildly high PTH; it was drawn at six weeks (24 ng/mL, insufficient), vitamin D3 was started, and the clinic's new-CKD order set was checked. Synthetic findings introduced: a lapse at four weeks with a PEth of 36 ng/mL, the fall in urine albumin from 240 to 96 mg/g, and the expected 9 percent dip in eGFR two weeks after dapagliflozin.
- **Consultation.** The nephrology referral and the consultation by Teodor Mbatha-Rasmussen, MD (a fictional consultant), on the day of the two-week visit, are **S**. The consultant answers the five referral questions in line with what the record shows afterwards: chronic kidney disease G3b A2, most likely hypertensive with naproxen contributing, without a biopsy; losartan to 100 mg with potassium and creatinine checks and a systolic target below 120; dapagliflozin delayed until abstinence, then started at ten weeks; naltrexone rather than acamprosate; and no oral NSAIDs or opioids, with acetaminophen and short topical courses. Addiction medicine care is the clinic's weekly addiction-focused counseling, recorded in the alcohol plan.
